Bisphosphonates: Mechanisms of action

被引：824

作者：

Fleisch, H ^{[1
]}

机构：

[1] Univ Bern, Dept Pathophysiol, CH-3010 Bern, Switzerland

来源：

ENDOCRINE REVIEWS | 1998年 / 19卷 / 01期

关键词：

D O I：

10.1210/er.19.1.80

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：80 / 100

页数：21

共 272 条

[71] Cyclical intravenous clodronate in postmenopausal osteoporosis: Results of a long-term clinical trial [J].

Filipponi, P ;

Cristallini, S ;

Rizzello, E ;

Policani, G ;

Fedeli, L ;

Gregorio, F ;

Boldrini, S ;

Troiani, S ;

Massoni, C .

BONE, 1996, 18 (02) :179-184

[72]

FINERMAN GAM, 1981, METAB BONE DIS RELAT, V4, P337

[73] PAMIDRONATE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN RESORPTIVE BONE-DISEASE [J].

FITTON, A ;

MCTAVISH, D .

DRUGS, 1991, 41 (02) :289-318

[74] DICHLOROMETHYLENEBISPHOSPHONATE (CL2MBP) INHIBITS BONE-RESORPTION THROUGH INJURY TO OSTEOCLASTS THAT RESORB CL2MBP-COATED BONE [J].

FLANAGAN, AM ;

CHAMBERS, TJ .

BONE AND MINERAL, 1989, 6 (01) :33-43

[75] The bisphosphonate ibandronate, given daily as well as discontinuously, decreases bone resorption and increases calcium retention as assessed by Ca-45 kinetics in the intact rat [J].

Fleisch, H .

OSTEOPOROSIS INTERNATIONAL, 1996, 6 (02) :166-170

[76] DIPHOSPHONATES INHIBIT HYDROXYAPATITE DISSOLUTION IN VITRO AND BONE RESORPTION IN TISSUE CULTURE AND IN VIVO [J].

FLEISCH, H ;

RUSSELL, RGG ;

FRANCIS, MD .

SCIENCE, 1969, 165 (3899) :1262-&

[77]

Fleisch H., 1996, P1037

[78] BISPHOSPHONATES - PHARMACOLOGY AND USE IN THE TREATMENT OF TUMOR-INDUCED HYPERCALCEMIC AND METASTATIC BONE-DISEASE [J].

FLEISCH, H .

DRUGS, 1991, 42 (06) :919-944

[79] EFFECT OF PYROPHOSPHATE ON HYDROXYAPATITE AND ITS IMPLICATIONS IN CALCIUM HOMEOSTASIS [J].

FLEISCH, H ;

RUSSEL, RGG ;

STRAUMANN, F .

NATURE, 1966, 212 (5065) :901-+

[80] ISOLATION FROM URINE OF PYROPHOSPHATE, A CALCIFICATION INHIBITOR [J].

FLEISCH, H ;

BISAZ, S .

AMERICAN JOURNAL OF PHYSIOLOGY, 1962, 203 (04) :671-&

← 3 4 5 6 7 8 9 10 11 12 →